Platform enables doctors to optimise patient treatment through remote monitoring of key blood biomarkers.
CardioRenal has raised €3.3M across 1 funding round from 1 investor, most recently a round in Apr 2022. Based in Grenoble, France; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-04-04 | Other | €3.3M |
| Business Angels |
| View deal → |
